Sp1003

PRESENTATION OF GASTROINTESTINAL ONCOLOGY (GIONC) SECTION RESEARCH MENTOR AWARD: SAPNA SYNGAL, MD, MPH

Date
May 8, 2023
Explore related products in the following collection:

Society: AGA

Presenters

Speaker Image for Elena Stoffel
University of Michigan

Tracks

Related Products

Thumbnail for ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for REMOTE GENETIC EDUCATION, RISK ASSESSMENT, AND TESTING (GENERATE) FOR PANCREATIC CANCER: A RANDOMIZED CLINICAL TRIAL
REMOTE GENETIC EDUCATION, RISK ASSESSMENT, AND TESTING (GENERATE) FOR PANCREATIC CANCER: A RANDOMIZED CLINICAL TRIAL
BACKGROUND AND AIMS: Although high body mass index (BMI) increased the risk of colorectal cancer (CRC), the impact of BMI change
Thumbnail for MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…